275 related articles for article (PubMed ID: 28083675)
1. Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.
Yohn SE; Alberati D; Correa M; Salamone JD
Psychopharmacology (Berl); 2017 May; 234(9-10):1525-1534. PubMed ID: 28083675
[TBL] [Abstract][Full Text] [Related]
2. Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
Yohn SE; Collins SL; Contreras-Mora HM; Errante EL; Rowland MA; Correa M; Salamone JD
Neuropsychopharmacology; 2016 Feb; 41(3):686-94. PubMed ID: 26105139
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing.
Farrar AM; Pereira M; Velasco F; Hockemeyer J; Müller CE; Salamone JD
Psychopharmacology (Berl); 2007 Apr; 191(3):579-86. PubMed ID: 17072593
[TBL] [Abstract][Full Text] [Related]
4. The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure.
Mott AM; Nunes EJ; Collins LE; Port RG; Sink KS; Hockemeyer J; Müller CE; Salamone JD
Psychopharmacology (Berl); 2009 May; 204(1):103-12. PubMed ID: 19132351
[TBL] [Abstract][Full Text] [Related]
5. Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors.
Nunes EJ; Randall PA; Podurgiel S; Correa M; Salamone JD
Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt A):2015-25. PubMed ID: 23583616
[TBL] [Abstract][Full Text] [Related]
6. The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists.
Yohn SE; Santerre JL; Nunes EJ; Kozak R; Podurgiel SJ; Correa M; Salamone JD
Pharmacol Biochem Behav; 2015 Aug; 135():217-26. PubMed ID: 26022661
[TBL] [Abstract][Full Text] [Related]
7. Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms.
Randall PA; Lee CA; Podurgiel SJ; Hart E; Yohn SE; Jones M; Rowland M; López-Cruz L; Correa M; Salamone JD
Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25575584
[TBL] [Abstract][Full Text] [Related]
8. The monoamine-oxidase B inhibitor deprenyl increases selection of high-effort activity in rats tested on a progressive ratio/chow feeding choice procedure: Implications for treating motivational dysfunctions.
Yohn SE; Reynolds S; Tripodi G; Correa M; Salamone JD
Behav Brain Res; 2018 Apr; 342():27-34. PubMed ID: 29292157
[TBL] [Abstract][Full Text] [Related]
9. Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists.
Pardo M; López-Cruz L; San Miguel N; Salamone JD; Correa M
Psychopharmacology (Berl); 2015 Jul; 232(13):2377-91. PubMed ID: 25647696
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological studies of effort-related decision making using mouse touchscreen procedures: effects of dopamine antagonism do not resemble reinforcer devaluation by removal of food restriction.
Yang JH; Presby RE; Jarvie AA; Rotolo RA; Fitch RH; Correa M; Salamone JD
Psychopharmacology (Berl); 2020 Jan; 237(1):33-43. PubMed ID: 31392358
[TBL] [Abstract][Full Text] [Related]
11. The dopamine depleting agent tetrabenazine alters effort-related decision making as assessed by mouse touchscreen procedures.
Yang JH; Presby RE; Rotolo RA; Quiles T; Okifo K; Zorda E; Fitch RH; Correa M; Salamone JD
Psychopharmacology (Berl); 2020 Sep; 237(9):2845-2854. PubMed ID: 32561947
[TBL] [Abstract][Full Text] [Related]
12. Partial reversal of the effort-related motivational effects of tetrabenazine with the MAO-B inhibitor deprenyl (selegiline): Implications for treating motivational dysfunctions.
Contreras-Mora H; Rowland MA; Yohn SE; Correa M; Salamone JD
Pharmacol Biochem Behav; 2018 Mar; 166():13-20. PubMed ID: 29309800
[TBL] [Abstract][Full Text] [Related]
13. The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.
Randall PA; Lee CA; Nunes EJ; Yohn SE; Nowak V; Khan B; Shah P; Pandit S; Vemuri VK; Makriyannis A; Baqi Y; Müller CE; Correa M; Salamone JD
PLoS One; 2014; 9(6):e99320. PubMed ID: 24937131
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in effort-related decision-making: role of dopamine D2 receptor antagonism.
Errante EL; Chakkalamuri M; Akinbo OI; Yohn SE; Salamone JD; Matuszewich L
Psychopharmacology (Berl); 2021 Jun; 238(6):1609-1619. PubMed ID: 33590311
[TBL] [Abstract][Full Text] [Related]
15. Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice.
Pardo M; Lopez-Cruz L; Valverde O; Ledent C; Baqi Y; Müller CE; Salamone JD; Correa M
Neuropharmacology; 2012 Apr; 62(5-6):2068-77. PubMed ID: 22261384
[TBL] [Abstract][Full Text] [Related]
16. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.
Nunes EJ; Randall PA; Hart EE; Freeland C; Yohn SE; Baqi Y; Müller CE; López-Cruz L; Correa M; Salamone JD
J Neurosci; 2013 Dec; 33(49):19120-30. PubMed ID: 24305809
[TBL] [Abstract][Full Text] [Related]
17. Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization.
Yohn SE; Arif Y; Haley A; Tripodi G; Baqi Y; Müller CE; Miguel NS; Correa M; Salamone JD
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3575-86. PubMed ID: 27497935
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding.
Rotolo RA; Kalaba P; Dragacevic V; Presby RE; Neri J; Robertson E; Yang JH; Correa M; Bakulev V; Volkova NN; Pifl C; Lubec G; Salamone JD
Psychopharmacology (Berl); 2020 Nov; 237(11):3459-3470. PubMed ID: 32770257
[TBL] [Abstract][Full Text] [Related]
19. The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology.
Rotolo RA; Presby RE; Tracy O; Asar S; Yang JH; Correa M; Murray F; Salamone JD
Neuropharmacology; 2021 Feb; 183():108325. PubMed ID: 32956676
[TBL] [Abstract][Full Text] [Related]
20. Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism.
Salamone JD; Farrar AM; Font L; Patel V; Schlar DE; Nunes EJ; Collins LE; Sager TN
Behav Brain Res; 2009 Jul; 201(1):216-22. PubMed ID: 19428636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
